Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria.

Song, Xiaoting; Liu, Bo; Yu, Miao; Liao, Shuanglu; Luan, Tingting; Li, Changling; Zhao, Zuotao

Song, Xiaoting; Liu, Bo; Yu, Miao; Liao, Shuanglu; Luan, Tingting; Li, Changling; Zhao, Zuotao.

Affiliation

Song X; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
Liu B; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.
Yu M; National Clinical Research Center for Skin and Immune Diseases, Beijing, China.
Liao S; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China.
Luan T; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
Li C; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.
Zhao Z; National Clinical Research Center for Skin and Immune Diseases, Beijing, China.

Int Arch Allergy Immunol ; 184(2): 199-201, 2023.

Article de En | MEDLINE | ID: mdl-36327946

Sujet(s)
Mots clés

Anaphylaxis; Chronic urticaria; Omalizumab

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Urticaire / Antiallergiques / Urticaire chronique / Anaphylaxie Limites: Adult / Humans Langue: En Journal: Int Arch Allergy Immunol Sujet du journal: ALERGIA E IMUNOLOGIA Année: 2023 Type de document: Article Pays d'affiliation: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google